It is a brand-name oral drug that contains the active ingredient sitagliptin, but no generic is available at this time
In SURMOUNT-1, tirzepatide at 515 mg once weekly produced even greater average weight loss in adults with obesity.[2] By contrast, structured research on true microdosing regimens is limited
Butyric acid, a naturally occurring short-chain fatty acid produced within the gut microbiome, has become an increasing focus of nutritional science due to its significant role in maintaining intestinal barrier integrity, supporting both microbial balance and natural GLP-1, the company shared, as well as contributing to overall digestive wellness.* The BIOMEnd ingredient utilizes l-lysine butyrate technology designed to improve oral delivery and utilization of butyric acid within dietary supplements
In this PermanenteDocs Chat, Alex McDonald, MD, speaks with Sean Hashmi, MD, nephrologist and obesity medicine specialist, about how clinicians should prescribe GLP-1 and other weight loss medications as part of a total weight management approach
These substances are toxic for your gut and can lead to inflammation and irritation in your gut